cspc - Search News

News

CSPC, AstraZeneca

AstraZeneca signs $5 billion research deal with China’s CSPC

AstraZeneca has signed a research agreement worth more than $5 billion with Chinese drugmaker CSPC Pharmaceutical Group, the Anglo-Swedish drugmaker said on Friday. The deal marks the latest effort by AstraZeneca to revive its business in China,

· 2d · on MSN

AstraZeneca Enters Deal With CSPC Pharma Valued at Up to $5.33 Billion

Fierce Biotech · 2d

AstraZeneca pens $5.3B pact to use CSPC's AI platform to develop oral drugs for chronic diseases

MedCity News2d

AstraZeneca Turns to CSPC Pharma Again, Putting Up $110M to Start Multi-Drug R&D Pact

AstraZeneca is paying CSPC Pharmaceutical Group $110 million up front to tap that China-based biotech’s artificial intelligence-driven technology for discovering and developing novel oral drugs.

KITV 4 Island News2d

Tech Talk: why it’s scary knowing Mattel is collab-ing with OpenAI

Davey D and Lina Girl discuss the hottest trends in technology from gaming to life-saving devices to apps that make you ...

Wall Street Journal2d

AstraZeneca Teams Up With CSPC Pharmaceuticals With Deal Valued at Up to $5.33 Billion

AstraZeneca said it entered into a strategic research collaboration with China’s CSPC Pharmaceuticals, focused on artificial intelligence-driven research, valued at up to $5.33 billion.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results